Shopping Cart
Remove All
Your shopping cart is currently empty
Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTAC degrader, specifically PROTAC B-Raf degrader 1, which exhibits anti-cancer activity[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $169 | 5 days | 5 days |
| Description | Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTAC degrader, specifically PROTAC B-Raf degrader 1, which exhibits anti-cancer activity[1]. |
| In vitro | Pomalidomide-amido-C1-Br (Compound 6) serves as a precursor for synthesizing PROTAC B-Raf degrader 1 (Compound 2), an effective anticancer agent that induces apoptosis in cancer cells by accelerating B-Raf degradation via the ubiquitin-proteasome system, affecting Mcl-1 expression, a downstream protein associated with B-Raf, highlighting its mechanism of action[1]. |
| Molecular Weight | 394.18 |
| Formula | C15H12BrN3O5 |
| Cas No. | 2351106-38-0 |
| Relative Density. | 1.808 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.